Roundup: Synapsica scales PACS, ClariPi launches CT denoising solution, and more briefings
AI Radiology company Synapsica expands PACS offering to more Indian cities
AI radiology reporting company Synapsica has partnered with GenWorks Health, a healthcare solutions provider powered by Wipro GE Healthcare, to bring imaging storage and communication systems (PACS) to multiple cities more across India.
Its Radiolens radioactivity process solution automatically detects poor quality scans and generates preliminary reports for most common procedures. It also provides actionable AI-driven qualitative and quantitative insights.
Through this partnership, access to radiology products will be available in more than 300 tier 2 and 3 cities and towns, such as Maharashtra, Andhra Pradesh, West Bengal and Chennai.
Synapsica is helping to address the shortage of radiologists in India, which currently numbers around 10,000 people per billion people. That, coupled with the growing demand for radiological reports, causes time strain on radiologists in examining reports, resulting in “insufficient” and “inaccurate” reporting. corpse” sometimes.
As a result, Radiolens assists radiologists by automating several tasks in their workflow while providing “deeper insights for a more objective outcome”.
“We are confident that GenWorks, with their extensive network, will bring our solution to healthcare providers in tier 2 and 3 towns and cities around the country, and allows us to help these hospitals and diagnostic laboratories produce high-quality radiological reports,” said Synapsica co-founder and CEO Meenakshi Singh.
Korean AI medical imaging startup unveils CT . removal solution
ClariPi, an AI medical imaging startup from Korea, has introduced its AI-powered low-dose CT denoising solution, along with its other new AI imaging products.
Trained with over a million images, ClariCT.AI removes image noise with a “significantly reduced” radiation dose.
The system, which has been removed in both the US and Europe, will be available in Nuance’s AI marketplace soon.
Meanwhile, ClariPi unveiled a software-based iodine contrast enhancement solution called ClariACE that minimizes the side effects of contrast-enhanced CT scans; ClariPulmo, a fully automated 3D reporting solution for COVID-19 pneumonia and emphysema; and ClariOsteo, an AI-powered precision bone health solution for both low-dose and ultra-low-dose CT imaging.
AICS presents its latest smart medical solutions
Taiwan-based ASUS Intelligent Cloud Services (AICS) has unveiled some of its latest smart medical solutions.
Its xHIS platform is a cloud-based, AI-based hospital information system that enables digitization by integrating AI services and optimizing the quality of medical record writing, coding system procedure, doctor issuing and ordering process, computerized doctor order entry service, etc. It has been implemented at Taipei Hospital, who claims that this system, when used in conjunction with with a clinical decision support system, will enhance multidisciplinary collaboration and communication between physician and patient.
The AICS Lumos EMR search platform analyzes medical records and examination reports. It also provides real-world data, such as variable trends and disease factors, that have supported research and clinical treatment at Chung Shan Medical University Hospital (CSMUH).
Another AICS product is the Drug Safety Service, developed in tandem with Cheng Hsin General Hospital. The AI-powered drug safety system looks at the individual and family health records of the patient and then recommends drugs and tests. It also flags if an unusual drug dose is prescribed, helping to reduce human error, disputes, and medical waste.
Finally, AICS has also worked with CSMUH to develop a personal health management platform. The CSMUH eServices App, powered by AICS Personal Healthcare Apps, provides a smart mobile clinic, chronic disease management, and long-term personalized care. It has a structured medical database that combines AI, mobile and telecommunications technologies.